Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:284169OMIM:616708Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion is a rare genetic condition caused by a small missing piece (microdeletion) on the short arm of chromosome 10, specifically in the region between bands p11.21 and p12.31. This syndrome is sometimes referred to as 10p11.21-p12.31 microdeletion syndrome. Because this chromosomal region contains several important genes, losing a copy of them can affect how the brain and body develop. People with this condition typically show distinctive facial features (facial dysmorphism), delays in reaching developmental milestones such as sitting, walking, and talking, and various behavioral challenges. The facial features may include a broad forehead, widely spaced eyes, a flat nasal bridge, and other subtle differences. Developmental delay can range from mild to moderate, and behavioral issues may include attention difficulties, hyperactivity, anxiety, or features on the autism spectrum. There is currently no cure for this condition. Treatment focuses on managing individual symptoms through therapies such as speech therapy, occupational therapy, physical therapy, and behavioral support. Early intervention programs can help children reach their full potential. Because the condition affects multiple body systems, a team of specialists is usually needed to provide comprehensive care. Each person's experience with this syndrome can vary depending on the exact size and location of the deletion.

Also known as:

Key symptoms:

Distinctive facial featuresDelayed speech and language developmentDelayed motor milestones like sitting and walkingIntellectual disability ranging from mild to moderateBehavioral problems such as hyperactivity or attention difficultiesFeatures on the autism spectrumLow muscle tone (floppiness in infancy)Feeding difficulties in early lifeShort stature or slow growthAnxiety or emotional difficultiesLearning difficulties in schoolWidely spaced eyesBroad or flat nasal bridgeSmall or receding chin

Clinical phenotype terms (46)— hover any for plain English
Ventricular hypertrophyHP:0001714Celiac diseaseHP:0002608Absent cupid's bowHP:0010800
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion.

View clinical trials →

No actively recruiting trials found for Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion community →

No specialists are currently listed for Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletionForum →

No community posts yet. Be the first to share your experience with Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion.

Start the conversation →

Latest news about Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion

1 articles
ResearchBIORXIVApr 12, 2026
Preprint: Complementary vertebrate Wac models exhibit phenotypes relevant to DeSanto-Shinawi Syndrome
Scientists created animal models (using fish and mice) that mimic DeSanto-Shinawi Syndrome, a rare genetic disorder caused by mutations in the WAC gene. These a
See all news about Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the exact size and location of my child's chromosomal deletion, and what genes are affected?,Was this deletion inherited or did it happen for the first time in my child?,What therapies should we start right away, and how often should they occur?,Are there any associated medical problems we should screen for, such as heart or growth issues?,What educational supports and accommodations should we request at school?,How will this condition affect my child's development over time?,Should other family members be tested for this chromosomal change?

Common questions about Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion

What is Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion?

Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion is a rare genetic condition caused by a small missing piece (microdeletion) on the short arm of chromosome 10, specifically in the region between bands p11.21 and p12.31. This syndrome is sometimes referred to as 10p11.21-p12.31 microdeletion syndrome. Because this chromosomal region contains several important genes, losing a copy of them can affect how the brain and body develop. People with this condition typically show distinctive facial features (facial dysmorphism), delays in reac

How is Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion inherited?

Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion typically begin?

Typical onset of Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion is infantile. Age of onset can vary across affected individuals.